App-safe HK / Shenzhen ops
All targets
MediumAI · Biotech50

GUTolution

A Hong Kong Science Park microbiome health-tech startup that runs an in-house sequencing lab, tests 5,000+ gut bacteria, and uses an AI engine to tailor-make and GMP-manufacture personalised probiotic formulas — the most relevant HK-based, consumer-facing precision-probiotic platform for a Week-1 Hong Kong meeting.

Location
Hong Kong Science Park, Pak Shek Kok · Hong Kong
Visit window
Best Jul 6–7 or Jul 11 · avoid Jul 8–10 (LEAP East)
Source status
high confidenceresearched

Next action

Keep the dossier ready and use the open questions if a visit window opens.

Why now: Visit window · Best Jul 6–7 or Jul 11 · avoid Jul 8–10 (LEAP East)

What they do

Delivers a personalised-microbiome service: an at-home gut-microbiome test, NGS sequencing in its own HKSTP lab (Illumina; profiles 5,000+ taxa), an AI analysis engine that produces a microbiome health score plus food/lifestyle/probiotic recommendations, and a bespoke GMP-manufactured probiotic formula with monthly cold-chain delivery, periodic re-testing/reformulation and nutritionist consults. Draws on HKU/CUHK clinical advisory input.

Why it matters

Secondary fit — a directly comparable consumer microbiome to AI to personalised-product playbook that maps onto the Coolvex consumer-health ambition (AI scoring, formulation, subscription cold-chain logistics), plus an early-stage, founder-accessible window into the HKSTP / HK Tech 300 microbiome ecosystem and its HKU/CUHK links. It personalises existing strains rather than mining novel ones, so it is secondary to the microbial-resource-discovery priority.

Visit objective & route

Run a peer-learning + ecosystem-mapping meeting and a potential AI-personalisation / consumer-go-to-market exchange for the Coolvex side — not a strain-sourcing deal.

Approach route

Direct / HK week — arrange via the site contact form ahead of travel; fold into an HKSTP ecosystem day.

Talking points

  • Does GUTolution do any novel-strain discovery or hold proprietary strains, or only personalise third-party probiotic strains?
  • Is there any topical/skin or postbiotic angle, or is it gut-only?
  • How do the AI scoring/personalisation engine and subscription cold-chain model work — lessons for a consumer-health line?
  • In-house GMP vs contract manufacturer for the personalised probiotics?

Open questions

  • Whether GUTolution does any novel-strain discovery or holds proprietary strains (current evidence: only personalises third-party strains).
  • Exact HKSTP unit/lab location and whether they take partner/founder visits.
  • Funding stage beyond the HK Tech 300 angel round; any 2024–2026 raise.
  • Whether there is any topical/skin or postbiotic angle (none found — appears gut-only).
  • Manufacturing: in-house GMP vs contract manufacturer.
  • Full founder/advisor roster and clinical-advisor affiliations (HKU/CUHK).

Risks & unknowns

  • Small early-stage startup with a consumer-services model and no own novel-strain IP found — not a strain-sourcing source.
  • Gut-focused only; no topical/skin or postbiotic angle found — limited direct read-across to a topical Coolvex line.

Private-pack boundary

Contact details, exact address, and appointment logistics are kept in your private pack — verify privately before outreach. This dossier holds public, app-safe intelligence only.